Category:

Facts

Latest

Chinese scientists develop gene therapy which could delay ageing

The method, detailed in a paper in the Science Translational Medicine journal earlier this month, involves inactivating a gene called kat7 which the scientists found to be a key contributor to cellular ageing.

The specific therapy they used and the results were a world first, said co-supervisor of the project Professor Qu Jing, 40, a specialist in ageing and regenerative medicine from the Institute of Zoology at the Chinese Academy of Sciences (CAS).

read more

Facebook to use AI in predicting if COVID-19 patients need better healthcare

According to Mashable, Facebook in a recent detailed blog post said that it had developed two AI models, one based on a single chest X-ray, and another from a series of X-rays that could help forecast if a patient infected by COVID-19 is likely to get worse. A third model predicts the amount of extra oxygen a COVID-19 patient might need.

read more

Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute

The vaccine maker also said that the vaccine recipient should also tell the healthcare provider about all the medical conditions before getting the Covishield vaccine including, “if you have ever had a severe allergic reaction (anaphylaxis) after any drug, food, any vaccine or any ingredients of Covishield vaccine”.

The recipients should also mention to the healthcare provider if they have fever, if they have a bleeding disorder or are on a blood thinner and also if they are immuno-compromised or are on a medicine that affects your immune system, it added.

read more

UK begins major trial for new inhaler-based Covid-19 treatment

“We need treatments as well as vaccines to fight highly pathogenic viruses such as SARS-CoV-2 [Covid-19]. Development of treatments like ours will remain necessary in cases where vaccines are not effective, for those who do not get vaccinated, and in case the virus mutates to the point where vaccines become less effective,” said Richard Marsden, CEO of Synairgen.

read more